INTRODUCTION {#h0.0}
============

Human cytomegalovirus (HCMV) is a betaherpesvirus found in 50% to 90% of human populations worldwide. Infection of healthy individuals usually involves an asymptomatic acute phase followed by lifelong carriage in a latent form ([@B1]). However, HCMV is a serious pathogen under conditions of immunoincompetence, being a leading cause of morbidity and mortality during congenital infection, bone marrow or solid organ transplantations, or AIDS ([@B1]). HCMV drives major metabolic reprogramming of host cells during infection ([@B2][@B3][@B5]). Akin to tumor cells ([@B6]), HCMV infection leads to an increase in glucose uptake ([@B7]) by upregulation of glucose transporter 4 (Glut4) ([@B8]). During infection, the flux of carbon through glycolysis is increased ([@B2], [@B3]), and glucose-derived citrate is shuttled from the mitochondria to the cytosol (cataplerosis) for the biosynthesis of fatty acids, vital for viral envelopment ([@B9]). HCMV also drives an increase in glutamine conversion to α-ketoglutarate to fuel the tricarboxylic acid (TCA) cycle with carbon (anaplerosis) ([@B10]). While in some cancer cells and in budding yeast the increase in glycolysis under aerobic conditions is associated with suppression of mitochondrial respiration and oxidative phosphorylation (OXPHOS), known as the "Crabtree effect" ([@B11], [@B12]), HCMV infection is associated with an increase in both glycolysis ([@B2]) and mitochondrial respiration ([@B13]). Mitochondria play a central role in production of cellular energy and biosynthetic precursors and are key mediators and regulators of apoptosis and antiviral signaling ([@B14]). They contain autonomous genomes that are expressed by unique transcription and translation systems, yet the human mitochondrial genome encodes only 13 polypeptides ([@B15]). The vast majority of mitochondrial proteins (700 to 1,000 in humans), including all of the protein components of the mitochondrial transcription and translation machineries, are encoded by nuclear genes, are translated in the cytosol, and are imported into mitochondria using dedicated translocons ([@B15]).

HCMV infection is known to profoundly affect mitochondria and their function. Previous studies have indicated that mitochondrial DNA (mtDNA) synthesis is stimulated by HCMV infection ([@B16]) and that upregulation of OXPHOS genes occurs late during HCMV lytic cycle at the level of transcription ([@B17]), translation ([@B18]), and protein expression ([@B19]). An increase in endoplasmic reticulum-mitochondrial contact domains by HCMV infection has also been documented ([@B20]). While the HCMV antiapoptotic protein UL37x1 ([@B21]) causes fragmentation of the mitochondrial network ([@B22]), this is not associated with perturbed mitochondrial physiological functions and therefore is different from other pathological conditions associated with network disassembly ([@B23]). On the contrary, HCMV-infected cells are known to have increased labeling with the membrane potential-dependent dye tetraphenylphosphonium (TPP) ([@B24]) and show increased oxygen consumption, indicative of induction of respiration ([@B13]). Viral UL37x1 may be involved in this process since a UL37x1 knockout virus was partially impaired in induction of respiration ([@B13]); HCMV β2.7 long noncoding RNA has also been suggested to affect mitochondrial function by binding respiratory complex I ([@B25]). In this case, β2.7 RNA was required to sustain ATP production throughout viral infection ([@B25]).

How HCMV upregulates mitochondrial biogenesis and function is not well understood. Here, we have used quantitative mass spectrometry (MS) to measure the changes in the mitochondrial proteome following HCMV infection in order to understand these processes. We found that multiple proteins of the mitochondrial transcription and translation systems were induced early during the viral replication cycle. This was accompanied by an increase in the components of the respiratory chain complexes encoded by the mitochondrial genome. Proteins involved in mitoribosome biogenesis were markedly induced by HCMV infection. Knockdown of a recently identified member of this group, MRM3 ([@B26], [@B27]), abrogated virus induction of mitochondrially encoded proteins and significantly impaired viral growth under bioenergetically restricting conditions.

RESULTS {#h1}
=======

Mapping HCMV-induced changes in the mitochondrial proteome using SILAC-MS. {#s1.1}
--------------------------------------------------------------------------

To better understand how HCMV stimulates mitochondrial biogenesis and functions, we mapped the HCMV-induced changes in the abundance of mitochondrial proteins using quantitative mass spectrometry (MS) based on stable isotope labeling by amino acids in cell culture (SILAC). We carried out a SILAC-based screen in U373 astrocytoma cells, which in our previous studies appear to be more sensitive to changes in mitochondrial function mediated by HCMV than fibroblasts ([@B25]) and gave higher yields and purity of mitochondria (unpublished results). Three parallel cultures of U373 cells were differentially labeled with SILAC media (containing "light," "heavy," or "medium" amino acids) and then infected with the HCMV Merlin strain for 48 or 60 h or mock infected (see [Fig. S1](#figS1){ref-type="supplementary-material"} in the supplemental material). Following infection, the three populations of cells were combined and mitochondria were isolated from the pooled-cell mixture by affinity purification. Lysed mitochondria were digested into peptides followed by MS. We identified 1,171 cellular proteins with at least 2 unique peptides in our mitochondrial preparation (see [Table S1A](#tabS1){ref-type="supplementary-material"} in the supplemental material). According to Gene Ontology (GO) annotation, 47% of identified proteins were mitochondrial, while 17% and 12% were annotated to the closely associated organelles the endoplasmic reticulum (ER) and the nucleus, respectively ([Fig. 1A](#fig1){ref-type="fig"}). At 48 h postinfection (hpi), over 20% of identified proteins exhibited a specific and significant change using a 2-fold cutoff ([Fig. 1B](#fig1){ref-type="fig"}). Virus-induced changes to mitochondrial proteins persisted up to 60 hpi (see [Fig. S2A](#figS2){ref-type="supplementary-material"} in the supplemental material) and were reproducible (see [Fig. S2B](#figS2){ref-type="supplementary-material"} and [Table S1B](#tabS1){ref-type="supplementary-material"}).

![SILAC-MS analysis of the changes in the mitochondrial proteome following HCMV infection. (A) Subcellular localization annotation of 1,171 human proteins identified in isolated mitochondria with at least 2 unique peptides represented as a percentage of the total. Gene Ontology (GO) information was imported using the UniProt database. (B) Scatter plot representing fold change in "heavy" (mock)/"light" (HCMV 48 hpi) protein abundance in isolated mitochondria. A total of 12.3% (144) of proteins were increased over 2-fold following HCMV infection (red), 8.6% (101) were downregulated (blue), and 79.1% (926) were not significantly changed (gray).](mbo0021627410001){#fig1}

HCMV reduces the association of mitochondria with proteins of other cellular structures and downregulates antiviral proteins. {#s1.2}
-----------------------------------------------------------------------------------------------------------------------------

To find functional groups within the proteins whose abundance was significantly changed by HCMV infection, we used the Database for Annotation, Visualization and Integrated Discovery (DAVID) ([@B28]). GO biological processes enriched within downregulated proteins included the categories "Cell adhesion," "Actin cytoskeleton organization," "Glycolysis," and "Response to virus" (see [Table S2A](#tabS2){ref-type="supplementary-material"} in the supplemental material). Reduction in actin binding proteins is consistent with HCMV disruption of the actin cytoskeleton ([@B29][@B30][@B31]). Given the documented activation of glycolysis by HCMV ([@B2], [@B3]), the observed reduction in glycolytic enzymes may appear counterintuitive. However, we found that glycolytic enzymes were not downregulated during infection in total cell extracts (our unpublished data); rather, the association of these enzymes with mitochondria was reduced in infected cells. Glycolytic enzymes are associated with mitochondria in mammalian cells ([@B32]). In plant cells ([@B33], [@B34]), the association of glycolytic enzymes with mitochondria is dynamically changed in response to respiratory demand ([@B35]). Whether HCMV-induced disassociation of glycolytic proteins from mitochondria has a metabolic role in HCMV replication remains to be determined. Of note, nonmitochondrial proteins were less associated with mitochondria upon infection, likely due to virus-induced fragmentation of the mitochondrial network ([@B22]).

In U373 cells, we observed a downregulation of several antiviral proteins (see [Table S2A](#tabS2){ref-type="supplementary-material"} in the supplemental material). Most significant was an 8.3-fold reduction in the proapoptotic and proautophagic protein BCL-2/adenovirus E1B interacting protein 3 (BNIP3). We also observed viral induction of acetyl-coenzyme A acyltransferase 2 (ACAA2), which was shown to mitigate apoptosis induced by BNIP3 ([@B36]). A reduction of the antiviral signaling proteins MAVS and STING, which act in interferon beta (IFN-β) induction through the IFN regulatory factor 3 (IRF3) pathway, was also seen. This reduction is in line with HCMV-induced downregulation of IRF3 ([@B19]) and inhibition of IFN-β induction ([@B37]). A reduction in STING has also previously been observed in total cell extracts of HCMV-infected fibroblasts ([@B19]), although no changes in total amounts or subcellular localization of MAVS were observed ([@B19], [@B38]). MAVS may therefore undergo different fates in HCMV-infected fibroblasts and U373 cells. Our data point to a reduction in two additional viral restriction factors implicated in the interferon response: gamma-interferon-inducible protein 16 (IFI16) and phospholipid scramblase 1. IFI16 is required for activation of the IRF3 signaling cascade during human herpes simplex virus 1 (HSV1) infection ([@B39]). IFI16 was also shown to restrict HCMV replication, yet its inhibitory activity was not dependent on IFN-β induction ([@B40]). Phospholipid scramblase 1, a restriction factor of hepatitis B virus ([@B41]), was shown to augment the IFN response by increasing the expression of potent antiviral genes ([@B42]).

Cellular pathways induced by HCMV infection. {#s1.3}
--------------------------------------------

DAVID analysis of HCMV-upregulated proteins showed enrichment of several cellular pathways, which included the KEGG_PATHWAY categories "Arginine and proline metabolism," "Fatty acid metabolism," and "One carbon pool by folate" (see [Table S2B](#tabS2){ref-type="supplementary-material"} in the supplemental material).

Within arginine metabolism-related proteins, the highest induction (8.7-fold) was found in arginase II (ARG2). [l]{.smallcaps}-Arginine is the source for the synthesis of nitric oxide (NO), which plays a major role in host defense against microbial infection. In mouse macrophages, induction of arginase II was shown to prevent NO production by depleting intracellular arginine pools ([@B43]). Induction of arginase II was also previously detected during herpes simplex virus 1 (HSV-1) infection of cornea ([@B44]). Consequently, it may be that arginase II induction aids herpesviruses to suppress a host NO antiviral response.

Fatty acid synthesis is induced by HCMV infection ([@B9]). In particular, very-long-chain fatty acids are important for the production for infectious virions ([@B45]). HCMV-induced lipogenesis requires the inhibition of beta oxidation of long-chain fatty acids and is mediated by recruitment of the cellular protein viperin to mitochondria ([@B46], [@B47]). Interestingly, we found that proteins involved in beta oxidation of short and medium fatty acids were induced by HCMV (see [Table S2B](#tabS2){ref-type="supplementary-material"} in the supplemental material). These included the mitochondrial short-chain-specific acyl coenzyme A (acyl-CoA) dehydrogenase (SCAD \[2.3-fold induction\]) and medium-chain-specific acyl-CoA dehydrogenase (MCAD \[4.4-fold induction\]), which catalyze the first step of oxidation of these fatty acids. It also included mitochondrial acetyl-coenzyme A acyltransferase 2 (ACAA2 \[3-fold induction\]), which catalyzes the last step of oxidation. In contrast, we found that the carnitine/acylcarnitine carrier protein, required for transport of long fatty acids into mitochondria, as well as the very-long-chain fatty acid-specific acyl-CoA dehydrogenase and trifunctional protein (TFP) complex, which catalyze beta oxidation of long-chain fatty acids, were not significantly changed by HCMV infection; this is consistent with the documented suppression of this pathway by HCMV ([@B47]). Whether a specific increase in the oxidation of short-chain fatty acids is supportive of HCMV replication remains to be determined. The induction of one-carbon metabolism in mitochondria is discussed below.

Mitochondria from HCMV-infected cells were enriched with proteins containing predicted N-terminal mitochondrial targeting sequences. {#s1.4}
------------------------------------------------------------------------------------------------------------------------------------

By inspection of our list of mitochondrial proteins upregulated by infection, it appeared that mitochondrial matrix proteins are much more increased than proteins of the other mitochondrial subcompartments. As most matrix proteins contain N-terminal mitochondrial targeting peptides (mTP), we expected an enrichment of proteins displaying a high probability of containing an mTP in our data set. We identified mTP scores for all of our quantified proteins using the TargetP 1.1 server ([@B48]). We then plotted the TargetP score against the log heavy/light amino acid ratio (H/L ratio) (see [Fig. S3A](#figS3){ref-type="supplementary-material"} in the supplemental material). Proteins with a negative log ratio were relatively enriched in infected cells, which were labeled with light amino acids. We performed this analysis on data searched against the whole UniProt database (see Fig. S3Aa) and against the UniProt database of mitochondrial proteins only (annotated by Mitocarta \[[@B49]\]) (see Fig. S3Ab). In both cases, the averaged log (ratio) for high TargetP scores was significantly lower than the averaged log (ratio) for low scores, suggesting that proteins with high score of predicted mTP are indeed selectively enriched in HCMV-infected cells. Our findings may suggest that proteins containing an mTP are preferentially imported into mitochondria in infected cells. The reported increased accumulation of TPP in HCMV-infected cells ([@B24]) may indicate an increase in the mitochondrial membrane potential in infected cells, which is the driving force for import through the TIM complex into the matrix.

HCMV specifically upregulated proteins involved in expression of the mitochondrial genome. {#s1.5}
------------------------------------------------------------------------------------------

Thirty-three of the 144 (23%) proteins upregulated by HCMV function in expression and maintenance of the mitochondrial genome ([Table 1](#tab1){ref-type="table"}). This group comprised \~40% of virally upregulated proteins annotated "mitochondrial" by GO, emphasizing the enrichment of this functional group among mitochondrial proteins upregulated by infection. This group included proteins associated with the mitochondrial nucleoid, proteins involved in mitochondrial mRNA transcription and turnover, mitochondrial tRNA maturation enzymes, mitochondrial tRNA synthetases, components of the small and large subunits of the mitoribosome, and proteins involved in mitoribosome assembly ([Table 1](#tab1){ref-type="table"}). We have confirmed that the measured upregulation of mitochondrial expression proteins was not significantly biased by normalization due to different total amounts of heavy- and light-amino-acid-labeled mitochondrial proteins (see [Fig. S3B](#figS3){ref-type="supplementary-material"} and [Text S1](#textS1){ref-type="supplementary-material"} in the supplemental material).

###### 

Fold change and suggested functions of mitochondrial expression factors upregulated by HCMV infection

  Protein                                                        Gene(s)              H/L ratio (mock/48 hpi)   No. of unique peptides   Suggested mitochondrial function(s)                                                     Reference(s)
  -------------------------------------------------------------- -------------------- ------------------------- ------------------------ --------------------------------------------------------------------------------------- ----------------
  mTERF domain-containing protein 1, mitochondrial               *MREF3*, *MTERFD1*   0.16                      3                        Mitochondrial ribosome biogenesis (mouse)                                               [@B50]
  Mpv17-like protein 2                                           *MPV17L2*            0.19                      2                        Mitochondrial ribosome assembly (human)                                                 [@B51]
  Polymerase delta-interacting protein 2                         *POLDIP2*            0.22                      6                        Mitochondrial nucleoid associated (human)                                               [@B100]
  Putative methyltransferase NSUN4                               *NSUN4*              0.25                      3                        Mitochondrial ribosome assembly (human, mouse)                                          [@B52]
  28S ribosomal protein S27, mitochondrial                       *MRPS27*             0.23                      5                        Small mitochondrial ribosome subunit (bovine)                                           [@B101]
  GTPase Era, mitochondrial                                      *ERAL1*              0.25                      7                        Mitochondrial ribosome biogenesis (human)                                               [@B53], [@B54]
  39S ribosomal protein L38, mitochondrial                       *MRPL38*             0.26                      7                        Large mitochondrial ribosome subunit (bovine)                                           [@B102]
  39S ribosomal protein L37, mitochondrial                       *MRPL37*             0.27                      8                        Large mitochondrial ribosome subunit (bovine)                                           [@B102]
  Dimethyladenosine transferase 2, mitochondrial                 *TFB2M*              0.28                      5                        Mitochondrial transcription activation (mouse, human)                                   [@B103]
  28S ribosomal protein S9, mitochondrial                        *MRPS9*              0.28                      12                       Small mitochondrial ribosome subunit (bovine)                                           [@B101]
  28S ribosomal protein S31, mitochondrial                       *MRPS31*             0.30                      4                        Small mitochondrial ribosome subunit (bovine)                                           [@B101]
  RNA methyltransferase-like protein 1                           *MRM3*, *RNMTL1*     0.30                      2                        rRNA methyl transferase, mitochondrial ribosome biogenesis (mouse)                      [@B26], [@B27]
  GTP-binding protein 5                                          *GTPBP5*             0.31                      3                        Large mitochondrial ribosome associated, mitochondrial translation regulation (human)   [@B104]
  Dimethyladenosine transferase 1, mitochondrial                 *TFB1M*              0.34                      4                        Mitochondrial transcription (human)                                                     [@B103]
  ATP-dependent RNA helicase SUPV3L1, mitochondrial              *SUPV3L1*            0.35                      9                        DNA/RNA helicase, mitochondrial RNA turnover and processing (human)                     [@B105]
  Mitochondrial tRNA-specific 2-thiouridylase 1                  *TRMU*               0.35                      4                        Mitochondrial translation regulation (human)                                            [@B106]
  Probable asparagine-tRNA ligase, mitochondrial                 *NARS2*              0.37                      2                        tRNA synthetase (human)                                                                 [@B107]
  Mitochondrial ribonuclease P protein 1                         *TRMT10C*, *MRPP1*   0.38                      12                       Mitochondrial tRNA maturation (human)                                                   [@B108]
  G-rich sequence factor 1                                       *GRSF1*              0.39                      10                       Mitochondrial mRNA turnover, mitochondrial ribosome biogenesis (human)                  [@B109]
  Putative ATP-dependent RNA helicase DHX30                      *DHX30*              0.40                      23                       Mitochondrial translation regulation (human)                                            [@B110]
  Tyrosine---tRNA ligase, mitochondrial                          *YARS2*              0.42                      6                        Mitochondrial tRNA synthetase (human)                                                   [@B111]
  Methionyl-tRNA formyltransferase, mitochondrial                *MTFMT*              0.44                      2                        Mitochondrial translation (human)                                                       [@B112]
  28S ribosomal protein S29, mitochondrial                       *DAP3*               0.44                      11                       Small mitochondrial ribosome subunit (bovine)                                           [@B101]
  tRNA modification GTPase GTPBP3, mitochondrial                 *GTPBP3*             0.44                      4                        Mitochondrial translation regulation (human)                                            [@B113]
  SRA stem-loop-interacting RNA-binding protein, mitochondrial   *SLIRP*              0.45                      3                        Mitochondrial mRNA turnover (human)                                                     [@B114]
  Glycine---tRNA ligase                                          *GARS*               0.46                      6                        Mitochondrial tRNA synthetase (human)                                                   [@B115]
  28S ribosomal protein S22, mitochondrial                       *MRPS22*             0.46                      9                        Small mitochondrial ribosome subunit (bovine)                                           [@B101]
  Fast kinase domain-containing protein 5                        *FASTKD5*            0.47                      6                        Mitochondrial translation (human)                                                       [@B110]
  Single-stranded DNA-binding protein, mitochondrial             *SSBP1*              0.48                      8                        mtDNA replication                                                                       [@B116]
  Elongation factor G, mitochondrial                             *GFM1*               0.49                      13                       Mitochondrial translation (human)                                                       [@B117]
  Fast kinase domain-containing protein 2                        *FASTKD2*            0.49                      9                        Mitochondrial translation (human)                                                       [@B110]
  Zinc phosphodiesterase ELAC protein 2                          *ELAC2*              0.49                      9                        Mitochondrial tRNA maturation (human)                                                   [@B118]
  28S ribosomal protein S17, mitochondrial                       *MRPS17*             0.50                      3                        Small mitochondrial ribosome subunit (bovine)                                           [@B101]

The most significant upregulation within this group was in proteins only recently identified to play a role in mitoribosome biogenesis, a process which is still poorly understood. We observed a 6-fold viral induction of mTERF3 ([@B50]), a 5-fold induction of MPV17L2 ([@B51]) and a 4-fold increase in NSUN4 ([@B52]), ERAL1 ([@B53], [@B54]) and MRM3 (RNMTTL1) ([@B26], [@B27]). Translation of mitochondrial proteins, like bacterial proteins, requires an initiating formylated methionine. The formyl group is supplied by one-carbon metabolism ([@B55]). Consistent with this, we also observed an upregulation of enzymes that participate in one-carbon metabolism in the mitochondria, including mitochondrial bifunctional methylenetetrahydrofolate dehydrogenase (MTHFD2 \[5.2-fold\]), monofunctional C1-tetrahydrofolate synthase (MTHFD1L \[2.2-fold\]), and mitochondrial methionyl-tRNA formyltransferase (MTFMT \[2.3-fold\]).

Taken together, our SILAC data suggest that regulation of mitochondrial translation is a key process in viral induction of mitochondrial biogenesis. This is in line with a previous report showing that chloramphenicol (which specifically inhibits mitochondrial translation) abrogates HCMV induction of mitochondrial respiration ([@B13]).

In contrast to the upregulation of mitochondrial genome expression factors, the vast majority of nucleus-encoded proteins of the respiratory complexes were not affected by HCMV infection (see [Table S3](#tabS3){ref-type="supplementary-material"} in the supplemental material). Exceptions to this were several proteins suggested to be involved in assembly of the respiratory complexes, which involves the integration of nuclearly and mitochondrially encoded proteins (highlighted in green in [Table S3](#tabS3){ref-type="supplementary-material"}). These proteins included the complex I assembly factors, evolutionarily conserved signaling intermediate in Toll pathway (ECSIT), Mimitin (NDUFAF2) and NDUFAF7, and complex III mitochondrial chaperone BCS1, as well as complex IV cytochrome *c* oxidase assembly factor 7.

Upregulation of mitochondrial expression factors occurs early during the HCMV replication cycle. {#s1.6}
------------------------------------------------------------------------------------------------

We next used Western blot (WB) analysis to confirm the changes detected in mitochondrial expression factors in our SILAC-MS analysis and obtained a good correlation of measurements between methods (see [Fig. S2C](#figS2){ref-type="supplementary-material"} in the supplemental material). Consistent with our SILAC-MS data, we observed an upregulation of components of the small and large mitoribosomal subunits (MRPS 18b, with MRPL12 more significant for the former), mitochondrial ribosome biogenesis factors (mTERF3 and MRM3), and mitochondrial transcription factors (TFAM and TFB2M) in U373 cells at 48 hpi ([Fig. 2](#fig2){ref-type="fig"}, left lanes). ATP5A a nuclearly encoded subunit of respiratory complex V, and the mitochondrial outer membrane protein porin (VDAC1) were not upregulated by HCMV infection of U373 cells, consistent with our SILAC data. We also analyzed if this upregulation occurs during HCMV infection of human fibroblasts, where induction of OXPHOS genes was previously shown ([@B17], [@B19]), and found that upregulation of mitochondrial expression proteins was more pronounced in HCMV-infected fibroblasts ([Fig. 2](#fig2){ref-type="fig"}, right lanes). In line with our SILAC-MS data, a minor upregulation of ATP5A and porin was observed in infected fibroblasts, consistent with the documented overall increase in mitochondrial biogenesis in these cells ([@B13], [@B17], [@B19]).

![Upregulation of mitochondrial translation and transcription factors in HCMV-infected cells. U373 and human fibroblast (HFFF2) cells were either mock infected or infected with HCMV (Merlin) at an MOI of 5 for 48 h. WB analysis of total cell extracts using the indicated antibodies is shown. The fold change in protein abundance measured by WB is presented in the column charts.](mbo0021627410002){#fig2}

We performed a time course analysis to determine the kinetics of viral induction of mitochondrial expression factors using MRM3 and TFB2M as representative proteins of the mitochondrial translation and transcription machineries. In both U373 and fibroblast cells, the accumulation of MRM3 and TFB2M was evident by 24 hpi, and they continued to accumulate through the viral replication cycle ([Fig. 3A](#fig3){ref-type="fig"}). Since upregulation was more robust in fibroblasts, we continued our analysis in these cells. mtDNA copy number also increased during HCMV infection at later stages of the viral replication cycle, in agreement with previous reports (see [Fig. S4](#figS4){ref-type="supplementary-material"} in the supplemental material) ([@B13], [@B16]). This increase could lead to an induction of mitochondrially encoded transcripts (mRNAs and rRNAs). However, an increase in the levels of mitochondrially encoded mRNAs *per se* may not be sufficient (or even required) for increased synthesis of mitochondrially encoded proteins as it was recently suggested that mammalian mitochondria (*in vivo*) contain a great excess of mitochondrial transcripts ([@B56]). Of note, the 2.7-fold increase in mtDNA observed at 72 hpi is comparable to the \~3-fold increase in mtDNA synthesis (as measured by ^3^H-dT incorporation) at 68 hpi observed by Furukawa et al. ([@B16]) and the 3.5-fold increase in mitochondrial mass (as assessed by nonyl acridine orange staining) observed by Kaarbø et al. ([@B13]). The \~300-fold increase in mtDNA at 72 hpi reported by Kaarbø et al. ([@B13]) was higher than our data suggest.

![Upregulation of mitochondrial expression factors occurs during the early phase of HCMV replication. (A) Time course analysis. U373 and HFFF2 cells were either mock infected or infected with HCMV (Merlin) at an MOI of 5 for the times indicated. Lysates were processed and analyzed as described in the legend to [Fig. 2](#fig2){ref-type="fig"}. Membranes were labeled with the indicated antibodies. The upregulation of mitochondrial expression factors was first observed at 24 hpi concomitant with the expression of the HCMV UL44 early protein. m., mock infected cells. (B) Induction of mitochondrial expression factors is dependent on the expression of immediate early/early but not late HCMV genes. HFFF2 cells were either mock infected or infected with an intact or a UV-inactivated HCMV (Merlin) at an MOI of 5 for 48 h.](mbo0021627410003){#fig3}

Our results suggest that the upregulation of MRM3 and TFB2M involves early or possibly immediate early (IE) viral gene expression. Consistent with this, no upregulation of MRM3 and TFB2M was observed when cells were infected with a UV-inactivated virus (which failed to produce the viral IE proteins) ([Fig. 3B](#fig3){ref-type="fig"}), and their induction was not perturbed by the viral DNA polymerase inhibitor phosphonoformic acid (PFA), which blocks viral late gene expression (marked by HCMV pp28) ([Fig. 3B](#fig3){ref-type="fig"}). The induction of MRM3 and TFB2M was also observed at the level of mRNA (see [Fig. S5](#figS5){ref-type="supplementary-material"} in the supplemental material), supporting the view that viral regulation of these genes is likely to be transcriptional.

HCMV genes known to target mitochondria are dispensable for induction of mitochondrial expression factors. {#s1.7}
----------------------------------------------------------------------------------------------------------

Two HCMV gene products have previously been shown to affect mitochondrial respiration: the UL37x1 protein and the long noncoding β2.7 RNA. A UL37x1 knockout virus was partially impaired in induction of respiration ([@B13]), while a β2.7 knockout virus failed to maintain ATP production throughout the viral infection cycle ([@B25]). We therefore determined whether the UL37x1 and β2.7 RNA genes are important for the induction of mitochondrial expression factors observed at early stage of HCMV replication. We found that neither UL37x1 nor β2.7 is required for viral induction of MRM3 and TFB2M ([Fig. 4](#fig4){ref-type="fig"}). The identity of the viral gene or genes that govern this induction remains to be determined.

![HCMV β2.7 and UL37x1 are not required for the induction of mitochondrial expression factors. HFFF2 cells were either mock infected or were infected for 48 h with wild-type (WT) HCMV (Merlin-BAC in panel A or Towne-BAC in panel B) or mutant viruses with the β2.7 (A) or UL37x1 (B) genes deleted.](mbo0021627410004){#fig4}

HCMV induces the production of mitochondrially encoded proteins. {#s1.8}
----------------------------------------------------------------

Having demonstrated that HCMV upregulates proteins of the mitochondrial transcription and translation machineries, we asked whether mitochondrial translation and the end products of these processes, mitochondrially encoded proteins, are also increased by HCMV infection. We first analyzed the assembly of mitochondrial ribosomal proteins following infection using sucrose gradient separation. We found an increase in assembled mitoribosomal subunits in the dense fractions using antibodies against the large (MRPL12) ([Fig. 5A](#fig5){ref-type="fig"}) and small (MRPS18b \[[Fig. 5A](#fig5){ref-type="fig"}\] and MRPS17 \[not shown\]) ribosomal subunits.

![HCMV induces the synthesis and stabilization of mitochondrially encoded proteins. (A) Assembled mitoribosomes are induced by HCMV. Equal amounts of proteins of total cell lysates from mock-infected or HCMV-infected HFFF2 cells at 48 hpi were separated on a linear sucrose gradient (10 to 30% \[wt/vol\]) and analyzed by WB. Free nonassembled ribosomal subunits (SSU, small subunit; LSU, large subunit) migrate to the lower fractions, while assembled mitoribosomes appear in the higher-density fractions. (B) Induction of mitochondrially encoded proteins by HCMV. HFFF2 cells were either mock infected or were infected with HCMV at an MOI of 5. After 2 h, the inoculum was washed, and cells were refreshed with untreated medium (UT) or with medium containing ethidium bromide (EtBr) to block mitochondrial transcription. Cells were harvested at 48 hpi, and lysates were processed and analyzed as described in the legend to [Fig. 2](#fig2){ref-type="fig"}. The chart shows the fold change in protein abundance. HCMV induces mitochondrial translation. (C to D) Mock-infected and HCMV-infected cells were radiolabeled with \[^35^S\]methionine at 24 hpi in the presence of emetine (which blocks cytosolic translation) to determine mitochondrial translation or in the absence of emetine to determine cellular translation. Total cell lysates were separated on a 4 to 12% Bis-Tris Plus PAGE. Equal loading of the gels was confirmed by staining the gel with Coomassie brilliant blue G-250. Dried gels were exposed to a phosphorimager screen and visualized using a phosphorimager scanner (C). Radioactive counts in cell lysates were measured directly or after TCA precipitation and used to calculate cellular and mitochondrial translation efficiencies, as described in the text. The chart shows the fold change in translation after infection (D).](mbo0021627410005){#fig5}

We next looked at steady-state levels of mitochondrially encoded proteins and found that mtDNA-encoded cytochrome oxidases 1 and 2 (mt-CO1 and mt-CO2), components of respiratory complex IV, were both upregulated after 48 h of infection of fibroblasts ([Fig. 5B](#fig5){ref-type="fig"}; see [Fig. S6A](#figS6){ref-type="supplementary-material"} in the supplemental material). In contrast, the levels of nuclearly encoded succinate dehydrogenase A (SDHA), part of respiratory complex II, were not significantly changed by infection. Of note, a moderate increase in mt-CO2 was observed in HCMV-infected U373 cells only at 72 hpi (see [Fig. S6B](#figS6){ref-type="supplementary-material"}) and not at 48 hpi (see [Fig. S6B](#figS6){ref-type="supplementary-material"} and [Table S1A and S1B](#tabS1 tabS1){ref-type="supplementary-material"} in the supplemental material). The increased upregulation of mitochondrially encoded proteins in infected fibroblasts compared to U373 cells correlates with the robust upregulation of mitochondrial transcription and translation factors in the former, as shown in [Fig. 2](#fig2){ref-type="fig"}.

We then followed mitochondrial translation by radiolabeling mock-infected and HCMV-infected cells with \[^35^S\]methionine in the presence of emetine, which specifically blocks cytosolic (but not mitochondrial) translation. When equal amounts of cell lysates were separated by SDS-PAGE and analyzed by autoradiography, we found that radiolabeling of mitochondrially encoded proteins was reduced after 24 h of HCMV infection ([Fig. 5C](#fig5){ref-type="fig"}, right lanes; see [Fig. S6C](#figS6){ref-type="supplementary-material"}, lanes 1 and 2, in the supplemental material). This was surprising since our WB analysis ([Fig. 5B](#fig5){ref-type="fig"}) suggested an increase in their steady-state levels. Moreover, we observed a significant decrease in the radiolabeling of cellular proteins (when labeling in the absence of emetine; [Fig. 5C](#fig5){ref-type="fig"}, left lanes). Since HCMV, unlike other viruses, maintains cellular translation and mTOR activation ([@B57]), we questioned if the decrease in radiolabeled proteins we observed resulted from a specific reduction in translation or reflected a reduction in \[^35^S\]Met uptake by infected cells under our experimental conditions. We, therefore, measured trichloroacetic acid (TCA)-precipitable counts (\[^35^S\]Met incorporated into proteins) and total radioactive count (including all \[^35^S\]Met taken up by the cells) in mock- and HCMV-infected cell lysates. We found that, indeed, total \[^35^S\]Met counts in infected cells (incorporated and nonincorporated \[^35^S\]Met) were reduced compared to those in mock-infected cells, suggesting that less \[^35^S\]Met was taken up by infected cells. We then calculated cellular and mitochondrial translation by dividing the TCA-precipitated counts by total counts, which represents the efficiency of \[^35^S\]Met incorporation into proteins and corrects for the biases in uptake of \[^35^S\]Met into the cells. When the above was taken into account, we found that mitochondrial translation is specifically induced at 24 h post-HCMV infection, while rates of cellular translation were similar between infected and uninfected cells ([Fig. 5D](#fig5){ref-type="fig"}). Nonetheless, we cannot exclude the possibility that HCMV perturbed cellular translation, which was accompanied by a decrease in uptake of \[^35^S\]Met, as translation inhibition was previously suggested to restrict uptake of at least some amino acids ([@B58]). In this case, our data would suggest a relative increase in mitochondrial translation over cytosolic translation in infected cells but not an absolute increase in mitochondrial translation compared to that in uninfected cells.

Interestingly, when uninfected cells were pretreated for 4 h with emetine prior to radiolabeling, mitochondrial translation was essentially blocked, while translation in HCMV-infected cells was maintained (see [Fig. S6C](#figS6){ref-type="supplementary-material"} in the supplemental material). It was previously shown that inhibition of cytosolic translation blocks mitochondrial translation within several hours, probably due to an elimination of a short-lived nucleus-encoded mitochondrial translation factor or factors ([@B59]). In sucrose gradients, we have observed an increase not only in assembled ribosomal subunits but also in nonassembled MRPL12 ([Fig. 5A](#fig5){ref-type="fig"}, fractions 1 to 4). Having a pool of mitochondrial translation factors (including nonassembled ribosomal subunits) may allow infected cells to retain mitochondrial translation under stress that blocks cytosolic translation.

To determine if the stability of mt-CO1 and mt-CO2 was also affected by viral infection, we blocked mitochondrial translation at 24 hpi using chloramphenicol and monitored the mt-CO1 and mt-CO2 levels at several time points. We found that the stability of both mt-CO1 and mt-CO2 was increased by infection (see [Fig. S6D](#figS6){ref-type="supplementary-material"} in the supplemental material). Blocking either mitochondrial transcription, using ethidium bromide (EtBr) ([Fig. 5B](#fig5){ref-type="fig"}), or mitochondrial translation (see [Fig. S6A](#figS6){ref-type="supplementary-material"}) immediately after viral inoculation caused, as expected, an almost complete elimination of mt-CO1 and mt-CO2 but not of nucleus-encoded SDHA from both infected and uninfected cells.

This inhibition of mitochondrial transcription and translation did not feed back to the nucleus to block expression of nucleus-encoded MRM3 and TFB2M (which are required for these processes); viral induction of both proteins was not impaired by EtBr or chloramphenicol treatments ([Fig. 5B](#fig5){ref-type="fig"}; see [Fig. S6A](#figS6){ref-type="supplementary-material"} in the supplemental material).

Inhibition of mitochondrial ribosome biogenesis interferes with viral growth. {#s1.9}
-----------------------------------------------------------------------------

Why might HCMV require an increase in mitochondrial gene expression? Blocking mitochondrial transcription or translation after viral infection did not affect the accumulation of immediate early or late viral proteins at 48 hpi, suggesting that expression of the mitochondrial genome is not required for viral gene expression ([Fig. 5B](#fig5){ref-type="fig"}; see [Fig. S6A](#figS6){ref-type="supplementary-material"} in the supplemental material). To evaluate the importance of mitochondrial translation for viral growth, we blocked mitochondrial translation after 24 h of infection (the earliest time point where we observed an induction in mitochondrial translation factors) and measured released virus titers at 120 hpi. Chloramphenicol treatment caused a statistically significant, yet very minor, \~2-fold reduction in virus titers when cells were grown on Dulbecco's modified Eagle's medium (DMEM) supplemented with glucose (5 mM) ([Fig. 6A](#fig6){ref-type="fig"}, compare the 1st column pair), a similar effect was reported previously ([@B13]). While not leading to cell death (not shown), this mild effect may result from a slightly poorer health of chloramphenicol-treated cells. No significant effect on titers was seen earlier during infection (at 3 days postinfection \[dpi\]), yet treatment of cells with chloramphenicol 24 h prior to infection caused a \>0.5-log reduction in viral titers (see [Fig. S6E](#figS6){ref-type="supplementary-material"} in the supplemental material). Importantly, we observed a robust \>1.5 log reduction of viral growth when mitochondrial translation was blocked under more restrictive conditions. For instance, cell growth on galactose as a major carbon source is more dependent on oxidative phosphorylation and is thus routinely used to test respiratory competence of cells ([@B60]). When HCMV-infected cells were shifted to growth on galactose at 24 hpi, only a minor reduction in virus titers at 120 hpi was observed compared to growth on media containing glucose ([Fig. 6A](#fig6){ref-type="fig"}, compare black columns 1 and 3). However, a significant \>1.5-log reduction in virus titers occurred when chloramphenicol was added to galactose-fed infected cells ([Fig. 6A](#fig6){ref-type="fig"}, compare the 3rd column pair), suggesting an important role for mitochondrial translation under demanding respiratory conditions. No significant death of infected cells was associated with growth on galactose either with or without chloramphenicol (data not shown). Impaired growth of cultured cells treated with chloramphenicol is driven by pyrimidine auxotrophy due to the requirement of a mitochondrial electron transport chain for the activity of dihydroorotate dehydrogenase (DHOdehase), a key enzyme in pyrimidine biosynthesis ([@B61]). Accordingly, supplementation of chloramphenicol-treated cells with uridine restores their growth to normal levels ([@B61]). Since pyrimidine biosynthesis is important for HCMV replication ([@B62]), and our SILAC-MS data show HCMV induction of DHOdehase (see [Table S1A](#tabS1){ref-type="supplementary-material"} in the supplemental material), we asked if supplementation of HCMV-infected cells with uridine would augment viral growth when mitochondrial translation was inhibited. However, uridine addition alone could not alleviate the inhibition of viral production on cells grown on galactose in the presence of chloramphenicol ([Fig. 6A](#fig6){ref-type="fig"}, compare 4th column pair). Thus, the requirement of mitochondrial translation is not due to impairment of pyrimidine production. This fits our observation that chloramphenicol does not prevent late viral protein production ([Fig. 5B](#fig5){ref-type="fig"}), as would be expected if pyrimidine biosynthesis was impaired. Taken together, our findings suggest that chloramphenicol inhibits viral replication due to an energetic deficiency.

![Inhibition of mitochondrial translation reduces virus titers. (A) HFFF2 cells were infected with HCMV at an MOI of 5 for 1 h and then washed and refreshed with DMEM supplemented with 10% dialyzed FBS, 2 mM glutamine, and antibiotics (DMEM-10dFBS) and 5 mM glucose. At 24 hpi, cells were washed and refreshed with DMEM-10dFBS containing either 5 mM glucose or 5 mM galactose with or without the addition of 0.2 mM uridine. Each medium was either left nontreated (nt) or was treated with chloramphenicol (50 µg/ml) to block mitochondrial translation. At 5 dpi, media were collected from cells, and released virus titers in supernatants were quantified using the 50% tissue culture infective dose (TCID~50~). Error bars represent the standard error of the mean (SEM) from two experiments with three replications each. (B and C) HFFF2 cells were transfected with a control siRNA or an siRNA targeting MRM3. After 22 h of transfection, cells were infected with HCMV (Merlin) at an MOI of 3, and at 24 hpi, cells were washed and refreshed with DMEM-10dFBS containing 5 mM galactose. At 5 dpi, media were collected from infected cells, and virus titers were quantified using the TCID~50~ (C). Cells were lysed and analyzed by WB; the results of two biological repeats are shown (B). The chart shows the fold change in protein abundance compared to control siRNA-treated cells. Error bars in panel C represent the standard errors from two biological repeats, each performed with three transfection replicates. \*, *P* \< 0.05; \*\*, *P* \< 0.001 (unpaired *t* test with Welch's correction).](mbo0021627410006){#fig6}

Our SILAC-MS data demonstrated that proteins involved in mitochondrial ribosome biogenesis are highly induced upon HCMV infection. On this basis, we asked if depletion of such a virally induced protein could prevent the induction of mitochondrial translation and impair viral growth. Consequently, we transfected fibroblasts with either a control small interfering RNA (siRNA) or siRNA directed against the virus-induced mitoribosomal biogenesis factor MRM3. After 16 h, cells were infected with HCMV and shifted to galactose medium at 24 hpi. At 120 hpi, we measured viral titers and analyzed cells by WB analysis. We found that depletion of MRM3 (\~20% relative to control siRNA) abrogated viral induction of the mitochondrially encoded CO2 (mt-CO2). In contrast, nucleus-encoded OXPHOS proteins were not significantly affected by MRM3 depletion ([Fig. 6B](#fig6){ref-type="fig"}). Concomitantly, knockdown of MRM3 significantly reduced viral titers ([Fig. 6C](#fig6){ref-type="fig"}), which mimicked the effect of chloramphenicol ([Fig. 6A](#fig6){ref-type="fig"}). Thus, viral induction of this mitoribosomal assembly factor appears important for viral growth.

DISCUSSION {#h2}
==========

HCMV has a profound effect on the expression of mitochondrial genes as well as on mitochondrial organization and functions. Here, we have affinity purified mitochondria and used quantitative MS to map the HCMV-mediated changes in the mitochondrial proteome. We found that in HCMV-infected U373 cells, over 20% of mitochondrially associated proteins were significantly modulated. We identified several antiviral factors that were downregulated by HCMV infection, which included proteins involved in regulation of the interferon response, a major target of HCMV ([@B37]). Interestingly, we found that a large group of mitochondrial proteins---all involved in mitochondrial gene expression---were significantly upregulated during infection. This upregulation was more robust in infected fibroblasts than in U373 cells, which is consistent with the more efficient viral replication in fibroblasts ([@B63]). The highest fold change occurred in proteins involved in the biogenesis of the mitoribosome. Although, the structure of the mitoribosome was recently resolved at high resolution ([@B64]), the process of mitoribosome biogenesis is still largely unknown, and most mitochondrial biogenesis factors we found to be virally induced have only recently been functionally annotated. It is tempting to speculate that additional mitochondrial proteins upregulated by HCMV infection that currently have no annotation might have a role in mitoribosome biogenesis.

HCMV induction of proteins involved in mitochondrial transcription and translation was correlated with an increase in \[^35^S\]methionine incorporation into mitochondrial proteins followed by an increase in steady-state levels of mitochondrially encoded proteins ([Fig. 5](#fig5){ref-type="fig"}). Interestingly, mitochondrially encoded proteins were induced by HCMV infection at times when gene expression of nucleus-encoded mitochondrial proteins was unchanged. Thus, the upregulation in the mitochondrial transcription and translation apparatuses may prime the biogenesis of the mitochondrial respiratory complexes. Several lines of biochemical evidence suggest that the mitochondrially encoded subunits may form a scaffold during the assembly of respiratory chain complexes that is then joined by nucleus-encoded subunits imported from the cytosol ([@B65], [@B66]).

Unlike the early induction of mitochondrial genome expression factors, the increase in mitochondrial DNA copy number ([@B13]) (see [Fig. S4](#figS4){ref-type="supplementary-material"} in the supplemental material) and in mitochondrial mass ([@B13]) occurs only at late stages of HCMV replication. A similar sequence of events occurs during *Arabidopsis* germination ([@B67]). In dry plant seeds, mitochondria appear in typical metabolically inert structures, termed promitochondria, and undergo rapid development and multiplication into mature metabolically active mitochondria following imbibition (the passive uptake of water by the seed) ([@B68], [@B69]). A detailed transcriptional analysis throughout the germination of *Arabidopsis thaliana* seeds revealed that transcripts encoding mtRNA transcription, editing and splicing factors peak early during germination. These are closely followed by transcripts of mitochondrial OXHPOS genes and by mitochondrial translation factors. The expression of nuclear OXHPOS genes lagged behind that of their mitochondrial counterparts ([@B67]). It may be that the sequence of events observed during the induction of mitochondrial biogenesis in HCMV-infected cells and in germinating *Arabidopsis* seeds represents an evolutionarily conserved process. Importantly, while mitochondrial translation precedes the increase in mitochondrial mass and mitochondrial DNA copy number during HCMV replication, it appears not to be essential for their induction as neither was blocked by chloramphenicol ([@B13]).

What controls mitochondrial biogenesis during HCMV replication? Our data strongly suggest that this is a virally driven process, as it requires active expression of the viral genome and fails to occur using a UV-inactivated virus. We show that mitochondrial expression factors start to accumulate at 24 hpi, suggesting that viral early genes are involved, although the involvement of IE gene expression cannot be excluded. However, neither UL37x1, an IE protein that localizes to mitochondria with early kinetics ([@B21], [@B22], [@B70], [@B71]), nor the early β2.7 noncoding RNA ([@B25]) (both with documented effects on mitochondrial function) was required for the induction of MRM3 and TFB2M ([Fig. 4](#fig4){ref-type="fig"}). The identities of the viral genes that govern this induction remain to be found.

The coordinated induction of mitochondrial transcription and translation factors is likely to be mediated by a cellular regulator, possibly activated by a viral gene product. Seo et al. have previously shown that at 24 h of HCMV infection, viral UL37x1 recruits the cellular protein viperin to mitochondria, where it interferes with fatty acid beta oxidation, causing a 50% reduction in cellular ATP ([@B46]). At 72 hpi, however, viperin was relocalized from mitochondria to the cytoplasmic viral assembly compartment ([@B46]). This may explain why we have not identified viperin by MS in our mitochondrial preparations at 48 or 60 hpi. We show that the induction of mitochondrial expression factors initiates at 24 hpi. While this induction was independent of UL37x1 ([Fig. 4](#fig4){ref-type="fig"}), it remains possible that mitochondrial biogenesis is induced to compensate for an initial perturbation of ATP synthesis which then allows ATP levels to be maintained later during HCMV infection. We have previously reported that following an initial (more subtle) reduction in cellular ATP following HCMV infection of U373 cells, ATP levels persist for at least 5 days postinfection ([@B25]). A compensatory increase in mitochondrial biogenesis was reported for multiple respiratory chain dysfunctions ([@B72][@B73][@B74]) and was proposed to explain an increase in mitochondrial mass in certain types of tumors ([@B75]).

Although several master regulators of mitochondrial biogenesis have been identified (reviewed in reference [@B76]), to our knowledge, there is no transcription factor yet known to specifically regulate the genes encoding mitochondrial transcription and translation proteins. Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) is a transcriptional coactivator that is induced under physiologic conditions that require mitochondria to produce heat or ATP ([@B76]). Although PGC-1α transcription is also induced during HCMV infection of fibroblasts ([@B13]), the late kinetics of induction of PGC1α by HCMV suggests that PGC-1α is not the initiator of induction of mitochondrial genome expression we observed during infection. However, PGC-1α may be involved in the late increase in mitochondrial mass. Nuclear respiratory factors 1 and 2 (Nrf1 and 2) are transcription factors that regulate the expression of nucleus-encoded respiratory complex subunits and genes involved in mtDNA transcription and replication, heme biosynthesis, and mitochondrial protein import ([@B76]). Nrf2, which also regulates antioxidant genes ([@B77]), is induced early during HCMV infection and protects infected cells from oxidative stress ([@B78]). Importantly, knockdown of Nrf2 does not cause any inhibition of HCMV growth under nonstressed conditions ([@B78]), unlike the reduction observed upon mitochondrial translation block ([@B13]) ([Fig. 6](#fig6){ref-type="fig"}). Nonetheless, involvement of Nrf2 in HCMV induction of mitochondrial expression factors cannot formally be excluded. Some genes involved in mitochondrial biogenesis are known to be regulated at the level of translation. mTORC inhibitors suppress the translation of mRNAs encoding components of respiratory complex V (ATP synthase), complex I assembly factors, as well as the major mitochondrial transcription factor TFAM and several mitoribosomal proteins ([@B79]). Analysis of total and polysome-associated mRNAs from HCMV-infected cells suggested that the translation of several mitoribosomal subunits was induced by the virus ([@B18]). Some OXPHOS and mitoribosomal proteins were translationally induced in noninfected cells expressing the HCMV mTORC1 activator UL38, while others, induced by the virus, were not induced by UL38 alone. Our analysis suggests that, at least for MRM3 and TFB2M mitochondrial expression factors (see [Fig. S5](#figS5){ref-type="supplementary-material"} in the supplemental material), regulation occurs at the level of transcription.

Our analysis showed that mitochondrial translation is important for HCMV replication, especially under conditions requiring active mitochondrial respiration. Specific inhibition of mitochondrial translation by chloramphenicol or by knockdown of the mitoribosome biogenesis factor MRM3 caused an \~1.5-log reduction in virus titers in galactose-fed cells ([Fig. 6A](#fig6){ref-type="fig"}). This inhibition of viral growth by chloramphenicol could not be rescued by the addition of uridine ([Fig. 6A](#fig6){ref-type="fig"}), previously shown to recover cell growth arrest by chloramphenicol ([@B61]). Taken together, these findings suggest that mitochondrial translation is important to keep mitochondria bioenergetically active during viral replication.

How do other viruses affect mitochondrial biogenesis? Rubella virus infection causes a significant increase in the activity of mitochondrial respiratory complexes II and III, as well as an increase in mitochondrial membrane potential and cellular ATP levels ([@B80], [@B81]). Increases in mitochondrial membrane potential and ATP also occur during persistent infection with measles virus ([@B82]). Similar to HCMV, these viruses also have protracted life cycles that may require prolonged maintenance of mitochondrial activity. Of note, among their many functions, interferons have been shown to inhibit mitochondrial gene expression ([@B83][@B84][@B86]), supporting the notion that mitochondrial function is supportive of viral replication. In contrast, many viruses with a short replication cycle interfere with mitochondrial activity ([@B87]). This is well demonstrated for HSV-1 and HSV-2, which unlike HCMV, have a much shorter replication cycle, that in culture ends with abrupt cytolysis of infected cells. Both HSV-1 infection and HSV-2 infection result in reduced levels of cellular ATP and mitochondrial membrane potential at late stages of HEp-2 infection ([@B88]). Similarly, the HSV-1 US3 protein is known to induce inhibition of mitochondrial respiration in HeLa cells ([@B89]). Moreover, in contrast to the induction of mtDNA synthesis by HCMV, HSV-1 encodes a mitochondrially targeted nuclease, UL12.5, which degrades mtDNA early during HSV-1 infection ([@B90]). Although the importance of mtDNA elimination for HSV-1 replication is not understood ([@B90]), it is clear that HSV-1 does not require active and proliferating mitochondria, apparently quite unlike HCMV. The importance of mitochondrial integrity as a cue for an immune response has recently become clear. mtDNA can serve as a stress signal both within and outside the cell. mtDNA released from cells induces inflammation by activation of polymorphonuclear neutrophils (PMNs) through CpG-Toll-like receptor 9 (TLR9) interactions ([@B91]). Within cells, mtDNA released from mitochondria during apoptosis is sensed by the cytosolic cGAS DNA sensor and leads to the induction of type I interferons ([@B92][@B93][@B94]). It will be interesting to determine whether, in addition to its metabolic and bioenergetic functions, induction of mitochondrial biogenesis is important for keeping HCMV-infected cells immunologically silent.

MATERIALS AND METHODS {#h3}
=====================

Cells and viruses. {#s3.1}
------------------

Primary human fetal foreskin fibroblast cells (HFFF2) and U373 cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (vol/vol) heat-inactivated fetal bovine serum (FBS), 100 µg/ml penicillin-streptomycin, and 2 mM [l]{.smallcaps}-glutamine at 37°C in 5% CO~2~. The HCMV strain Merlin ([@B95]) was used in all experiments, except if stated otherwise. The Towne-BAC (bacterial artificial chromosome) ΔUL37x1 mutant HCMV and its parental strain ([@B96]) were a kind gift from E. Mocarski (Emory University School of Medicine, Atlanta, GA). The Merlin BAC-derived clone was used for the construction of a Δβ2.7 strain by recombineering (see [Text S1](#textS1){ref-type="supplementary-material"} in the supplemental material). For the SILAC experiment, media collected from HCMV (Merlin)-infected cells were spun at 13,530 *g* (average) for 2 h at 4°C to pellet viruses. Pellets were then resuspended in SILAC Minimum Essential Medium (lacking lysine and arginine) supplemented with 10% dialyzed FBS.

Virus infection. {#s3.2}
----------------

Cells seeded 1 day prior to infection were inoculated with HCMV at a multiplicity of infection (MOI) of 5 for 2 h unless indicated differently and washed once in medium. Where indicated, cells were incubated with PFA at 300 µg/ml, chloramphenicol at 50 or 100 µg/ml, and EtBr at 40 or 80 ng/ml from the time of infection onwards. For infection of the ΔUL37x1 mutant and its parental strain (where viral titers were low), we applied a spin infection protocol, in which plated cells were spun with virus for 30 min at 730 g at room temperature followed by 1 h of incubation in a humidified CO~2~ incubator.

SILAC. {#s3.3}
------

U373 cells were cultured in SILAC DMEM supplemented with 10% dialyzed FBS (dFBS), 100 µg/ml penicillin-streptomycin, and 2 mM [l]{.smallcaps}-glutamine. SILAC medium was supplemented with either "light" (Arg 0, Lys 0 \[Sigma\]), "medium" (Arg 6, Lys 4, \[Cambridge Isotope Laboratories\]), or "heavy" (Arg 10, Lys 8 \[Cambridge Isotope Laboratories\]) amino acids at 50 mg/liter and [l]{.smallcaps}-proline at 280 mg/liter. Incorporation of "heavy" label was \>98% for both arginine and lysine-containing peptides. Cells were propagated for 7 doublings in SILAC medium to enable incorporation of the labeled amino acids into cellular proteins. Twenty-four hours prior to infection, 75-cm^2^ flasks were seeded with 3.2 × 10^6^ cells. Two flasks were established for each SILAC medium ("light," "medium," and "heavy"). Cells were sequentially infected at an MOI of 3 with HCMV strain Merlin (prepared in SILAC DMEM). Mock-infected cells ("heavy") were inoculated with conditioned medium from HFFF2 cultured cells. Forty-eight-hour ("light") and 60-h ("medium") infections were staggered such that all flasks were harvested simultaneously. Infection efficiency was monitored using HCMV IE1 immunostaining.

Mitochondrial isolation. {#s3.4}
------------------------

Mitochondria were affinity purified using superparamagnetic microbeads conjugated to anti-TOM22 antibodies (Miltenyi Biotec) (see [Text S1](#textS1){ref-type="supplementary-material"} in the supplemental material).

Mass spectrometry and data analysis. {#s3.5}
------------------------------------

Mass spectrometric analysis, database searching, and data processing were performed as described previously ([@B97]). Briefly, for the three-label experiment ([Fig. 1](#fig1){ref-type="fig"}; see [Table S1A](#tabS1){ref-type="supplementary-material"} in the supplemental material), mitochondrial protein extracts were separated by gel electrophoresis and divided into 24 gel slices followed by in-gel trypsin digestion. Liquid chromatography-tandem MS (LC-MS/MS) was performed using a NanoAcquity ultraperformance liquid chromatograph (uPLC) (Waters, Milford, MA) coupled to an LTQ-OrbiTrap XL (Thermo Scientific, Tampa, FL). Peptides were eluted using a gradient rising to 25% MeCN by 70 min and 45% MeCN by 80 min. MS data were acquired between 300 and 2,000 *m*/*z* at 60,000 full width at half-maximum (fwhm). Collision-induced dissociation (CID) spectra were acquired in the LTQ device with MS/MS switching operating in a top-6 data-dependent acquisition (DDA) fashion triggered at 500 counts.

For the two-label biological repeat (see [Fig. S2B](#figS2){ref-type="supplementary-material"} and [Table S1B](#tabS1){ref-type="supplementary-material"} in the supplemental material), mitochondrial protein extracts were dialyzed and trypsinized on a column as described previously ([@B97]). Eluted peptides were fractionated off-line by high-pH reverse-phase high-performance liquid chromatography (HpRP-HPLC) using a Dionex UltiMate 3000 powered by an ICS-3000 SP pump with an Agilent Zorbax Extend-C~18~ column (4.6 mm by 250 mm, 5-µm particle size). Mobile phases (H~2~O plus 0.1% NH~4~OH or MeCN plus 0.1% NH~4~OH) were adjusted to pH 10.5 with the addition of formic acid, and peptides were resolved using a linear 40-min 0.1% to 40% MeCN gradient over 40 min at a flow rate of 400 µl/min and a column temperature of 15°C. Eluting peptides were collected in 15-s fractions. LC-MS/MS was performed on 42 combined fractions as described above but with a gradient rising to 45% MeCN by 100 min and MS/MS triggered at 1,000 counts.

Raw data files were processed as previously described ([@B97]) using MaxQuant version 1.3.0.5 ([@B98]) and a merged *Homo sapiens*/HCMV strain Merlin UniProt database (downloaded 9/5/14). Gene ontology cellular compartment (GOCC) terms were added using the UniProt database ([@B99]).

Pathway analysis. {#s3.6}
-----------------

The Database for Annotation, Visualization and Integrated Discovery (DAVID) was used to determine Gene Ontology biological processes (GOTERM_BP) and KEGG pathway enrichment ([@B28]). The groups of virus-induced downregulated and upregulated proteins were searched against a background of all proteins quantified within the relevant experiment.

Analysis of the mitochondrial ribosome profile on density gradients. {#s3.7}
--------------------------------------------------------------------

Total cell lysates in (50 mM Tris-HCl, 150 mM NaCl, 1% Triton X-100, supplemented with protease inhibitor cocktail \[Roche\]) were loaded on a linear sucrose gradient (2 ml 10 to 30% \[wt/vol\]) in a mixture of 50 mM Tris-HCl (pH 7.2), 10 mM Mg(OAc)~2~, 40 mM NH~4~Cl, and 25 mM KCl and centrifuged for 2 h 15 min at 100,000 × *g*~max~ at 4°C (39,000 rpm \[Beckman Coulter TLS-55 rotor\]). Twenty fractions (100 µl each) were collected, and 10-µl aliquots of the first 17 fractions containing mitoribosomal subunits and assembled mitoribosomes were analyzed by WB.

Mitochondrial translation analysis. {#s3.8}
-----------------------------------

Mock-infected and HCMV-infected cells were incubated for 30 min in [l]{.smallcaps}-methionine-free DMEM supplemented with 10% dialyzed fetal bovine serum (dFBS) and emetine (100 µg/ml) to block cytosolic translation and 250 µCi/ml \[^35^S\]methionine (EasyTag [l]{.smallcaps}-\[^35^S\]methionine \[PerkinElmer, Waltham, MA\]). For total cellular translation, 25 µCi/ml was used without emetine. After labeling, cells were washed twice with excess phosphate-buffered saline (PBS) before lysis with cold radioimmunoprecipitation assay (RIPA) buffer supplemented with complete protease inhibitor cocktail (Sigma-Aldrich). Insoluble material was removed from the lysate by centrifugation for 10 min at 10,000 × *g* at 4^ο^C. Equal amounts of protein were spotted onto Whatman filter papers in 4 replicates. After drying, two replicates were used to measure the total counts per minute (\[^35^S\]Met incorporated into proteins + \[^35^S\]Met taken up by the cells yet not incorporated), while two replicates were TCA precipitated to measure the acid-insoluble portion (\[^35^S\]Met incorporated into proteins only) by incubation of 20 min in cold 10% TCA, boiling for 15 min in 5% TCA, and washing in 5% TCA followed by washing in 95% ethanol and drying. Radioactive counts were measured after addition of Ultima Gold scintillation liquid (PerkinElmer) using a Tri-Carb 1500 liquid scintillation analyzer (PerkinElmer). Translation was calculated as TCA-precipitated counts/total counts. For autoradiography analysis, lysates were separated on 4 to 12% Bis-Tris Plus PAGE, after which the gel was stained with Coomassie brilliant blue G-250 (to confirm equal loading), dried, exposed to a phosphorimager screen, and visualized using a FLA5100 scanner (Fujiimager, Tilburg, The Netherlands).

Analysis of the stability of mitochondrially encoded proteins. {#s3.9}
--------------------------------------------------------------

Mock-infected or HCMV-infected cells at 24 hpi were treated with chloramphenicol (50 µg/ml) to block mitochondrial translation. Cell extracts were made after 0, 6, 12, 24, and 30 h of addition of chloramphenicol and analyzed by WB for mt-CO2, mt-CO1, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a loading control.

Effect of chloramphenicol treatment on viral titers. {#s3.10}
----------------------------------------------------

Cells were infected with HCMV (Merlin) at an MOI of 5 for 1 h, washed once, and refreshed with DMEM supplemented with 10% dFBS, penicillin/streptomycin, and 2 mM [l]{.smallcaps}-glutamine (DMEM-10dFBS) and 5 mM glucose. At 24 hpi, cells were washed and refreshed with DMEM-10dFBS medium containing either 5 mM glucose or 5 mM galactose (galactose-DMEM-10dFBS) with or without the addition of 0.2 mM uridine. Each medium was either left untreated or treated with chloramphenicol (50 µg/ml) to block mitochondrial translation. At 5 dpi, media were collected from cells and kept at −80°C until assayed for determination of viral titers (see [Text S1](#textS1){ref-type="supplementary-material"} in the supplemental material). Cells were tested for propidium iodide exclusion to determine viability.

siRNA knockdown of MRM3. {#s3.11}
------------------------

RNA interference (RNAi) duplexes (see [Text S1](#textS1){ref-type="supplementary-material"} in the supplemental material) were delivered to 10^5^ cells in 12-well culture plates 1 day prior to infection with HCMV using oligofectamine transfection reagent (Life Technologies). Infection was carried out at an MOI of 3 in penicillin-streptomycin-free DMEM-glucose. After 24 h of infection, cells were shifted to galactose-DMEM-10dFBS. After 5 days of infection, media were collected from cells and spun at 800 g for 10 min at 18°C. Supernatants were kept frozen at −80°C until assayed for viral titers. The experiment included three transfection replicates and two biological repeats. Of the three replicate wells, one well was harvested for WB analysis, while the remaining two wells were used to determine cell viability by trypan blue exclusion using a Countess automated cell counter (Life Technologies).

SUPPLEMENTAL MATERIAL {#sm1}
=====================
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Supplemental experimental procedures. Download
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Text S1, DOCX file, 0.03 MB
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Work flow of SILAC-MS analysis of the mitochondrial proteome following HCMV infection. U373 cells were cultured for 7 passages in "light," "heavy," or "medium" SILAC-DMEM. Cells were infected at an MOI of 3 with HCMV strain Merlin. The 48-h and 60-h infections were staggered such that all flasks were harvested simultaneously. Prior to mitochondrial isolation, the 3 cell populations were mixed. Cells were then homogenized, and mitochondria were isolated by affinity purification using superparamagnetic microbeads conjugated to anti-TOM22 antibodies. Purified mitochondria were lysed, and extracted proteins were separated by SDS-PAGE and trypsin digested. Peptides were eluted and analyzed by LC-MS/MS Download
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Figure S1, PDF file, 0.2 MB
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\(A\) Comparison of the mitochondrial proteome of U373 cells between 48 and 60 h of HCMV infection. Shown is a scatter plot representing the fold change in "heavy" (mock)/"medium" (HCMV 60 hpi) (*y* axis) compared to "heavy" (mock)/"light" (HCMV 48 hpi) (*x* axis), with both axes displayed using a log~2~ scale. The changes in abundance of mitochondrially associated proteins relative to those in mock-infected cells were nearly identical after 48 and 60 h of HCMV infection. (B) An independent biological repeat of the SILAC experiment shows similar changes in the mitochondrial proteome following HCMV infection. Shown is a scatter plot representing the fold change in "heavy" (mock)/"light" (HCMV 48 hpi) in two independent biological repeats, with both axes displayed using a log~2~ scale. Protein ratios show a high degree of correlation between experiments. (C) WB measurements correlate with SILAC data. The fold changes in abundance of mitochondrial proteins at 48 hpi presented in [Fig. 2](#fig2){ref-type="fig"} were assessed by densitometric analysis and compared to the values obtained in the SILAC-MS analysis (average of values from [Table S1A](#tabS1){ref-type="supplementary-material"} and S1B). Download
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###### 

\(A\) Proteins with high mTP scores are enriched in infected cells. TargetP scores were plotted against log (H/L ratio) for the whole UniProt database (a) and against the UniProt database of mitochondrial proteins only (annotated by Mitocarta \[b\]). Proteins with a negative log ratio were relatively enriched in infected cells, which were labeled with light amino acids (red arrow). The significance of difference in the average log (ratio) between populations defined by TargetP 0 to 0.1 and 0.9 to 1 or TargetP 0 to 0.2 and 0.8 to 1 was calculated using a 2-tailed *t* test (2 samples, unequal variance). (B) Fold change measurements were not biased by differences in total amounts of heavy- and light-labeled mitochondrial proteins. Raw MS files were searched using MaxQuant, and fold changes in protein abundance at 48 hpi were calculated, employing 3 databases: a, all human proteins; b, all human proteins with mitochondrial proteins removed; c, all mitochondrial proteins only (annotated by Mitocarta). Pairwise comparison of ratios for data searched against databases b versus a and c versus a are presented. Download
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mtDNA is upregulated at late stages of HCMV replication. HFFF2 cells were either mock infected or infected with HCMV at an MOI of 5 for 24, 48, or 72 h. Total DNA was extracted from cells, and the relative expression of mtDNA was determined using quantitative PCR (qPCR). Column charts show the fold change in mtDNA compared to that in mock-infected cells at 24 hpi. Error bars represent standard errors from two biological repeats. Download
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TFB2M and MRM3 are induced at the level of mRNA following HCMV infection. HFFF2 cells were either mock infected or infected with HCMV at an MOI of 5 for 48 h. Total RNA was extracted from cells, and the relative expression of TFB2M and MRM3 mRNAs was determined using reverse transcription-quantitative PCR (RT-qPCR) using *GAPDH* and *POLR2L* as the reference genes. Column charts show the fold change in mRNA expression in HCMV-infected over mock-infected cells. Error bars represent standard errors from two biological repeats. Download
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\(A\) Induction of mitochondrially encoded proteins by HCMV was blocked by chloramphenicol. HFFF2 cells were either mock infected or infected with HCMV at an MOI of 5. After 2 h, the inoculum was washed and cells were refreshed with untreated medium (UT) or with medium containing chloramphenicol to block mitochondrial translation. Cells were harvested at 48 hpi, and lysates were processed and analyzed by WB. (B) mt-CO2 was induced in infected U373 cells only at 72 hpi. HFFF2 cells were either mock infected or infected with HCMV for 48 or 72 h. Cells were harvested and lysates were processed and analyzed by WB. The charts in panels A and B show the fold changes in protein abundance after viral infection. (C) Blocking cytosolic translation abrogated mitochondrial translation in mock-infected but not in HCMV-infected cells. Mock-infected and HCMV-infected cells were radiolabeled with \[^35^S\]methionine either with or without 4 h of pretreatment with emetine (which blocks cytosolic translation). Total cell lysates were separated by 15% SDS-PAGE. Equal loading of the gels was confirmed by staining the gel with Coomassie brilliant blue G-250. Dried gels were exposed to phosphorimager plates and scanned. (D) Mitochondrially encoded proteins are stabilized by HCMV infection. Mock-infected or HCMV-infected HFFF2 cells were treated with chloramphenicol at 24 hpi for the times indicated. Cell lysates were analyzed by WB. Graphs show the fold change in mt-CO1 and mt-CO2 over time relative to *t* = 0 (addition of chloramphenicol) normalized to GAPDH. (E) Pretreatment with chloramphenicol reduces viral growth on glucose-fed cells. Mock-infected or HCMV-infected HFFF2 cells were grown in DMEM supplemented with 5 mM glucose (as described in the legend to [Fig. 6A](#fig6){ref-type="fig"}) and were either left untreated or treated with chloramphenicol (50 µg/ml) either 24 h prior to or 24 h after HCMV infection**.** At 3 dpi, media were collected from cells, and released virus titers were quantified using TCID~50~. Error bars represent the standard errors from two experiments with two replications each. \*, *P* \< 0.05 (unpaired *t* test with Welch's correction). Download

###### 

Figure S6, PDF file, 1.7 MB
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Quantitation of mitochondrially associated proteins upon HCMV infection. (A) Triple-labeling SILAC experiment. (B) Double-labeling SILAC experiment.
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\(A\) GO biological processes enriched within virus-downregulated proteins. (B) KEGG pathways enriched within virus-upregulated proteins.
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Quantitation of OXPHOS subunits and assembly factors upon HCMV infection.
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Table S3, XLSX file, 0.02 MB
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